Medicus Pharma CFO acquires 29,069 common shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Medicus Pharma Ltd. (MDCX) President and CFO Carolyn F. Bonner acquired 29,069 common shares on November 13, 2026, at $1.72 per share. She held 58,859 common shares directly after the transaction. No Rule 10b5-1 plan is reported.
Insider Trade Summary
Grant/Award: 29,069 shares
Grant/Award
1 txn
Insider
Bonner Carolyn F.
Role
President and CFO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Shares, no par value F1 | 29,069 | $1.72 | $50K |
Holdings After Transaction:
Common Shares, no par value — 58,859 shares (Direct)
Footnotes (1)
- F1. On November 13, 2026, Carolyn F. Bonner entered into a subscription agreement with the Issuer, pursuant to which Ms. Bonner agreed to purchase 29,069 common shares, no par value, at a purchase price of $1.72 per share in a private placement in which other investors also participated under separate subscription agreements.
Key Figures
Common shares acquired: 29,069 shares
Price per share: $1.72 per share
Direct common shares held after transaction: 58,859 shares
3 metrics
Common shares acquired
29,069 shares
Carolyn F. Bonner's transaction on November 13, 2026
Price per share
$1.72 per share
Subscription agreement for the November 13, 2026 transaction
Direct common shares held after transaction
58,859 shares
Carolyn F. Bonner's reported position following the transaction
Key Terms
subscription agreement, private placement
2 terms
subscription agreement financial
"entered into a subscription agreement"
A subscription agreement is a legal contract in which an investor agrees to buy a specific number of a company’s shares or other securities under set terms, including price, payment method and conditions for closing the sale. It matters to investors because it legally locks in their purchase and the company’s obligations, determines ownership percentage and any investor rights, and can include conditions or promises that affect future control or returns—like signing a detailed purchase order for equity.
private placement financial
"in a private placement"
A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.